Terms of Service

Last Updated: February 2026

Agreement to Terms

By accessing 483 Signal, you agree to these Terms of Service. If you do not agree to all the terms and conditions of this agreement, you may not access the service.

What This Is Not

483 Signal does not provide:

  • Legal advice
  • Regulatory consulting
  • Facility-specific compliance guidance
  • Inspection preparation services

This is a data aggregation and analysis platform, not professional advice.

User Representations

By using this service, you represent and warrant that:

  • You are at least 18 years of age
  • You understand that all content is for educational purposes only and does not constitute legal, regulatory, or professional advice
  • You will consult qualified professionals (attorneys, regulatory consultants, quality experts) before making compliance decisions for your organization
  • You will not rely solely on the content provided by this service for regulatory compliance decisions
  • You have the legal capacity to enter into these Terms of Service

Subscriptions

Free Newsletter:

  • No cost, no payment information required
  • Unsubscribe anytime via email footer link

Paid Memberships:

  • Professional and Enterprise tiers available
  • Auto-renewal via Stripe; cancel anytime via account settings
  • 30-day full refund policy
  • See pricing page for current plans

Data Accuracy Disclaimer

AUTOMATED PROCESSING MAY CONTAIN ERRORS

483 Signal uses automated text extraction from PDF documents, algorithmic classification of GMP categories and facility types, and confidence-scored regulatory timeline linking. This automated processing may introduce errors, inaccuracies, or omissions.

Users must verify all information against the original FDA documents before relying on any content. Original FDA Warning Letters and Form 483s are available from official government sources.

We make no representation or claims regarding the accuracy, completeness, or fitness for any particular purpose of the extracted content.

Disclaimer of Warranties

ALL CONTENT IS PROVIDED "AS IS" WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED.

483 Signal aggregates and classifies publicly available FDA enforcement data. Risk assessments, classifications, and regulatory timeline links represent 483 Signal's analytical opinion and are not official FDA assessments. We expressly disclaim all warranties, including but not limited to implied warranties of merchantability, fitness for a particular purpose, non-infringement, and any warranties arising out of course of dealing or usage of trade. Companies may have taken corrective actions not yet reflected in public records.

This is not legal or regulatory advice. Consult qualified professionals for compliance decisions.

Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW:

  • Cap on Damages: In no event shall 483 Signal's total liability to you exceed the amount you have paid to us in the twelve (12) months immediately preceding the event giving rise to such liability, or one hundred dollars ($100), whichever is greater.
  • Exclusion of Consequential Damages: In no event shall 483 Signal be liable for any indirect, incidental, special, consequential, or punitive damages, including but not limited to loss of profits, data, business opportunities, or goodwill, regardless of whether we were advised of the possibility of such damages.
  • Data Processing Errors: We shall not be liable for any damages arising from errors, inaccuracies, or omissions in automated text extraction, OCR processing, classification, risk scoring, or regulatory timeline linking.
  • Decisions Based on Content: We shall not be liable for any decisions you make, actions you take, or compliance outcomes based on the content provided through this service.

Some jurisdictions do not allow the exclusion or limitation of certain damages. If these laws apply to you, some or all of the above exclusions or limitations may not apply, and you may have additional rights.

Indemnification

You agree to indemnify, defend, and hold harmless 483 Signal, its affiliates, officers, directors, employees, agents, and licensors from and against any claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys' fees) arising out of or related to:

  • Your use of the service
  • Your violation of these Terms of Service
  • Your violation of any applicable laws or regulations
  • Any decisions or actions you take based on the content provided
  • Any claim that your use of the service caused damage to a third party

Dispute Resolution and Arbitration

PLEASE READ THIS SECTION CAREFULLY. IT AFFECTS YOUR LEGAL RIGHTS.

Agreement to Arbitrate:

You and 483 Signal agree that any dispute, claim, or controversy arising out of or relating to these Terms or your use of the service shall be resolved by binding arbitration, rather than in court, except that either party may bring claims in small claims court if they qualify.

Arbitration Rules:

Arbitration shall be conducted by the American Arbitration Association (AAA) under its Consumer Arbitration Rules. The arbitration will be conducted in English, and judgment on the award rendered may be entered in any court having jurisdiction.

Class Action Waiver:

YOU AND 483 SIGNAL AGREE THAT EACH MAY BRING CLAIMS AGAINST THE OTHER ONLY IN YOUR OR ITS INDIVIDUAL CAPACITY AND NOT AS A PLAINTIFF OR CLASS MEMBER IN ANY PURPORTED CLASS OR REPRESENTATIVE PROCEEDING. The arbitrator may not consolidate more than one person's claims and may not otherwise preside over any form of representative or class proceeding.

Small Claims Exception:

Notwithstanding the foregoing, either party may bring an individual action in small claims court for disputes within the court's jurisdictional limits.

Governing Law:

These Terms and any dispute arising out of or related to these Terms or the service shall be governed by and construed in accordance with the laws of the State of Delaware, United States, without regard to its conflict of law provisions.

DMCA and Copyright

Government Works:

FDA Warning Letters and Form 483 Inspection Reports authored by FDA personnel are works of the United States Government and are in the public domain pursuant to 17 U.S.C. § 105. Firm-submitted content within recall reports and company responses may be subject to third-party copyright. Our analysis and commentary on these public documents constitutes fair use under 17 U.S.C. § 107.

Our Content:

The original classification methodology, data aggregation, company profiles, regulatory timeline analysis, and compilation of materials on this site is protected by copyright. You may not reproduce, distribute, or create derivative works from our original content without permission.

DMCA Takedown Procedure:

If you believe that content on our site infringes your copyright, please send a notice containing:

  • Identification of the copyrighted work claimed to have been infringed
  • Identification of the infringing material and its location on our site
  • Your contact information
  • A statement of good faith belief that the use is not authorized
  • A statement, under penalty of perjury, that the information is accurate
  • Your physical or electronic signature

Send DMCA notices to: contact@483signal.com

Modifications to Terms

We reserve the right to modify these Terms at any time. We will provide notice of material changes by updating the "Last Updated" date at the top of this page. Your continued use of the service after any such changes constitutes your acceptance of the new Terms.

Severability

If any provision of these Terms is found to be unenforceable or invalid, that provision will be limited or eliminated to the minimum extent necessary so that these Terms will otherwise remain in full force and effect.

Contact

Questions about these terms: contact@483signal.com